Last edition
News about "Kalpesh Kikani"
Biodeal Pharmaceuticals Concludes Piramal Alternatives Partnership
Biodeal delivered strong revenue growth during the hold period, with EBITDA margins improving alongside continued investment in manufacturing and governance.
Kalpesh Kikani | 28/07/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members